Infection-related complications after common infection in association with new antibiotic prescribing in primary care: retrospective cohort study using linked electronic health records.
adverse events
epidemiology
health informatics
health policy
infectious diseases
quality in health care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
15 01 2021
15 01 2021
Historique:
entrez:
16
1
2021
pubmed:
17
1
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Determine the association of incident antibiotic prescribing levels for common infections with infection-related complications and hospitalisations by comparing high with low prescribing general practitioner practices. Retrospective cohort study. UK primary care records from the Clinical Practice Research Datalink (CPRD GOLD) and SAIL Databank (SAIL) linked with Hospital Episode Statistics (HES) data, including 546 CPRD, 346 CPRD-HES and 338 SAIL-HES practices. Initial general practice visit for one of six common infections and the proportion of antibiotic prescribing in each practice. Incidence of infection-related complications (as recorded in general practice) or infection-related hospital admission within 30 days after consultation for a common infection. A practice with 10.4% higher antibiotic prescribing (the IQR) was associated with a 5.7% lower rate of infection-related hospital admissions (adjusted analysis, 95% CI 3.3% to 8.0%). The association varied by infection with larger associations in hospital admissions with lower respiratory tract infection (16.1%; 95% CI 12.4% to 19.7%) and urinary tract infection (14.7%; 95% CI 7.6% to 21.1%) and smaller association in hospital admissions for upper respiratory tract infection (6.5%; 95% CI 3.5% to 9.5%) The association of antibiotic prescribing levels and hospital admission was largest in patients aged 18-39 years (8.6%; 95% CI 4.0% to 13.0%) and smallest in the elderly aged 75+ years (0.3%; 95% CI -3.4% to 3.9%). There is an association between lower levels of practice level antibiotic prescribing and higher infection-related hospital admissions. Indiscriminately reducing antibiotic prescribing may lead to harm. Greater focus is needed to optimise antibiotic use by reducing inappropriate antibiotic prescribing and better targeting antibiotics to patients at high risk of infection-related complications.
Identifiants
pubmed: 33452190
pii: bmjopen-2020-041218
doi: 10.1136/bmjopen-2020-041218
pmc: PMC7813359
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e041218Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: All authors have completed the ICMJE uniform disclosure form and declare: BvB, VP, CM, DA and TvS report grants from the Department of Health and Social Care for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Références
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii36-ii43
pubmed: 29490058
Clin Infect Dis. 2000 Jun;30(6):931-3
pubmed: 10880303
BMC Med. 2020 Mar 2;18(1):40
pubmed: 32114981
Ann Fam Med. 2019 May;17(3):231-238
pubmed: 31085527
Cochrane Database Syst Rev. 2013 Nov 05;(11):CD000023
pubmed: 24190439
BMJ. 2013 Nov 25;347:f6867
pubmed: 24277339
BMC Fam Pract. 2006 Nov 13;7:68
pubmed: 17096861
J Antimicrob Chemother. 2018 Oct 1;73(10):2883-2892
pubmed: 29955785
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
BMJ. 2019 Feb 27;364:l525
pubmed: 30814048
Lancet Infect Dis. 2014 Mar;14(3):213-9
pubmed: 24440616
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Int J Antimicrob Agents. 2018 Dec;52(6):790-798
pubmed: 30145249
BMJ. 1997 Aug 9;315(7104):350-2
pubmed: 9270458
Br J Gen Pract. 2007 Jun;57(539):441-8
pubmed: 17550668
Cochrane Database Syst Rev. 2015 Jun 23;(6):CD000219
pubmed: 26099233
BMJ. 2007 Nov 10;335(7627):982
pubmed: 17947744
BMJ. 2012 Feb 02;344:d8173
pubmed: 22302780
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):19-26
pubmed: 29490060
BMJ. 2016 Jul 04;354:i3410
pubmed: 27378578
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
EClinicalMedicine. 2018 Dec;6:36-41
pubmed: 30740597